Annales de Biologie Clinique
MENUUnusual sulfamethoxazole crystalluria: key elements for their identification Volume 79, issue 1, Janvier-Février 2021
Figures
1 Département de biochimie et pharmaco-toxicologie, CHRU de Brest, Brest, France
2 Département de néphrologie, CHRU de Brest, Brest, France.
* Correspondence
- DOI : 10.1684/abc.2021.1624
- Page(s) : 94-5
- Published in: 2021
Sulfamethoxazole (SMX) is known to cause crystalluria. Several cases of renal impairment associated with precipitation of the SMX metabolite as crystals of N-acetylsulfamethoxazole hydrochloride (NASM) have been reported in the literature. Risk factors associated with the development of NASM crystals include high levels of SMX, low daily urine volume, urinary pH < 5.7, hypovolemia or dehydration, pre-existing renal insufficiency, and hypoalbuminemia [1]. The management of renal impairment due [...]